Salim Mathew, MD
Interventional Cardiology · Charlottesville, VANPI 1861468449
Payments from drug & device makers
Across 34 payments — averaging $130.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Abbott$2K
- Medtronic$656
- Abiomed$141
- Terumo Medical Corporation$138
Across 1 payment — averaging $240.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$240
What the payments were for
- Consulting fees$902%
- Travel & lodging$2,66260%
- Food & beverage$1,70138%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 12 | $1,832 |
| Abbott | 8 | $1,686 |
| Medtronic | 10 | $656 |
| Abiomed | 1 | $141 |
| Terumo Medical Corporation | 3 | $138 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIENCE SKYPOINT$1,512
- SYMPLICITY G3$239
- Resolute$133
- LUX-Dx Insertable Cardiac Monitor$121
How this compares
$4,452 in reported general payments places this provider in the 40th percentile of 176 interventional cardiology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 343 | $415,467 |
| XareltoRivaroxaban | 39 | $48,548 |
| EntrestoSacubitril/Valsartan | 44 | $45,469 |
| BrilintaTicagrelor | 13 | $16,116 |
| Repatha SureclickEvolocumab | 25 | $15,582 |
| Metoprolol Succinate | 372 | $5,122 |
| Atorvastatin Calcium | 254 | $2,784 |
| Olmesartan Medoxomil | 65 | $2,064 |
| Flecainide Acetate | 55 | $1,788 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 27 | $1,550 |
| Amiodarone Hcl | 30 | $983 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 112 | $815 |
| ClopidogrelClopidogrel Bisulfate | 81 | $799 |
| Losartan Potassium | 47 | $778 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 26 | $757 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Charlottesville
- Michael RagostaCharlottesville$1M
- John SaxonCharlottesville$900K
- Kanwar SinghCharlottesville$401K
- Angela TaylorCharlottesville$267K
- Saad GhummanCharlottesville$17K
- Deepak TalrejaVirginia Beach$2M
- Rajiv TayalFredericksburg$2M
- Jason FoerstRoanoke$956K
- Noah JonesFalls Church$907K
- Wayne BatchelorFalls Church$723K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.